AGPU - Predictive Oncology Inc.

1.83
0.120   6.557%

Share volume: 41,093
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$1.71
0.12
0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 25%
Dept financing 23%
Liquidity 11%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
2.81%
1 Month
-25.00%
3 Months
-62.65%
6 Months
90.43%
1 Year
60.53%
2 Year
-36.01%
Key data
Stock price
$1.83
P/E Ratio 
0.00
DAY RANGE
$1.69 - $1.85
EPS 
-$108.50
52 WEEK RANGE
$0.71 - $16.54
52 WEEK CHANGE
$71.03
MARKET CAP 
10.326 M
YIELD 
N/A
SHARES OUTSTANDING 
3.394 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$65,489
AVERAGE 30 VOLUME 
$49,351
Company detail
CEO: Raymond F. Vennare
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: 2010
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Predictive Oncology Inc. focuses on developing personalized cancer therapies using artificial intelligence (AI) The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures.

Recent news